Connect with us

Hi, what are you looking for?

Life

Trump’s pharmaceutical plan may be a start, but there is a catch

Health and Human Services Secretary Alex Azar speaking at a Brookings Institution event in Washington on Friday said he would push ahead with drug pricing reforms despite the pushback from the pharmaceutical industry.

“Finally seeing this system reformed, in fact, is one of the pharmaceutical industry’s ultimate nightmares. I can tell you that because it used to be my job to have pharmaceutical nightmares.” Azar is a former Eli Lily executive.

The Trump administration is going ahead with its plan to “substantially reduce the price of certain costly drugs administered under Medicare,” despite drugmakers charges the president’s plan would import “socialized” price controls.

Pharmaceutical manufacturing at BPL  Elstree  UK.

Pharmaceutical manufacturing at BPL, Elstree, UK.


Basically, Trump wants to tie what Medicare pays for certain drugs to the much lower prices paid for the same drugs in other economically advanced countries. However, the administration’s plan would only apply to Medicare Part B, which covers drugs administered in doctors’ offices.

One thing about the plan is certain – It is a “stunning move,” according to Forbes. If it works, it could force pharmaceutical and biotechnology companies to rethink their business models.

Forbes points out that Trump has said time and again that patented drug pricing is a bad deal for Americans. “For decades, other countries have rigged the system so that American patients are charged much more—and in some cases, much, much more—for the exact same drug,” Trump said. “In other words, Americans pay more, so that other countries can pay less.”

PhRMA — the deep-pocked trade group representing pharmaceutical companies in the U.S. jumped on the announcement of the plan on Thursday, arguing the plan would “jeopardize access to medicines.” On Friday, Azar pointed responded to the charge, saying “something has to change,” and this would give patients more access to needed medications.

In a study released by the administration on Thursday, data shows Medicare pays 80 percent more than other advanced industrial countries for some of the most expensive medicines administered at doctors’ offices.
The study found that overall, the prices paid for Medicare Part B drugs with the greatest expenditures in the U.S. exceeded the prices paid in countries with similar economic conditions. The amount by which U.S. prices exceeded those of international comparators varied significantly by product, and there was no clear pattern as to which countries were consistently paying lower prices. We find these higher U.S. prices mean that the Medicare program pays nearly twice as much as it would pay for the same or similar drugs in other countries.
The administration will accept public comments before implementing its proposal, which doesn’t require congressional approval., and right now, Trump does not have a whole lot of support from Congress and certainly not from the pharmaceutical industry.

Avatar photo
Written By

We are deeply saddened to announce the passing of our dear friend Karen Graham, who served as Editor-at-Large at Digital Journal. She was 78 years old. Karen's view of what is happening in our world was colored by her love of history and how the past influences events taking place today. Her belief in humankind's part in the care of the planet and our environment has led her to focus on the need for action in dealing with climate change. It was said by Geoffrey C. Ward, "Journalism is merely history's first draft." Everyone who writes about what is happening today is indeed, writing a small part of our history.

You may also like:

Business

South Korean ministries and police said Thursday they were blocking DeepSeek's access to work computers.

Business

Asian markets rose tracking gains on Wall Street and following the US Postal Service's U-turn on a ban on parcels from China and Hong...

World

As tech companies seek energy sources to meet these demands while maintaining their zero-carbon emission commitments, nuclear power has emerged as a compelling option...

World

Rubio, the son of Cuban immigrants and a devout Catholic, sparred bitterly with Trump during the 2016 election, but has steadily grown closer to...